The confirmation of the SARS-CoV-2 spike protein in vaccines may differ from its natural form, which is a potential safety concern across various vaccine types. — Whalespan
The confirmation of the SARS-CoV-2 spike protein in vaccines may differ from its natural form, which is a potential safety concern across various vaccine types.
⚠ High risk
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
◐PARTIALLYSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“you worry that the confirmation as made in under these conditions mrna or dna or replication defective or whole kill virus or recombinant dna generated proteins that it's different it's critically different than the way it sits on the virus surface”